Sugi Predict

Sugi Predict / Compounds / SCHEMBL7094845

SCHEMBL7094845

SCHEMBL7094845

Cc1ccc(N=CC=O)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.46
▸ MAPT P10636 7/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ CYP3A4 P08684 2/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ PMM2 O15305 1/20 0.35
▸ MPI P34949 1/20 0.35
▸ KMT2A Q03164 5/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.32
▸ TSHR P16473 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ S100B P04271 1/20 0.32
▸ CDC25A P30304 2/20 0.32
▸ CDC25B P30305 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ PABPC1 P11940 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5680929 0.85 ALDH1A1 (0.50) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL5920072 0.85 ALDH1A1 (0.50) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL13590029 0.84 ALDH1A1 (0.38) ALDH1A1MAPTCYP3A4TRPA1MPI
SCHEMBL13590020 0.84 CYP3A4 (0.47) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL14459432 0.82 KMT2A (0.44) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL12245133 0.78 NOTUM (0.35) ALDH1A1MAPTCYP3A4TRPA1KMT2A
SCHEMBL5920332 0.78 ALDH1A1 (0.45) ALDH1A1MAPTRAB9ACYP3A4PMM2
SCHEMBL13590027 0.77 S100B (0.50) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL14275467 0.76 ALDH1A1 (0.50) ALDH1A1MAPTRAB9ACYP3A4TRPA1
SCHEMBL7091916 0.76 ALDH1A1 (0.48) ALDH1A1MAPTRAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120295946-A1 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof National Institute of Health (NIH) 2012-11-22 — — US disclosed
US-8258172-B2 Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof RAPTOR PHARMACEUTICAL CORP (US) 2012-09-04 — — US disclosed
US-20110021594-A1 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof Raptor Pharmaceutical Corp. 2011-01-27 — — US disclosed
WO-2003084662-A2 COVALENTLY FIXED LIGAND SYSTEMS, NON-METALLOCENE SYSTEMS AND CATALYST SYSTEMS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF FOR POLYMERIZING OLEFINS CELANESE VENTURES GMBH (DE) 2003-10-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021594-A1 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof APP, BACE1, PSEN1 ALDH1A1 2149/4885MAPT 31/4885RAB9A 3232/4885
US-20120295946-A1 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof APP, BACE1, PSEN1 ALDH1A1 2149/4885MAPT 31/4885RAB9A 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.